With FDA's greenlight, will this be Triangle's next unicorn?

Triangle Business Journal

May 31, 2019

The FDA's approval of a gene therapy drug developed by a Novartis company is a big break for both patients and a private Triangle company -- one quickly approaching a $1 billion va…